Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Component DTaP Vaccine
- Development stage
- Preclinical
- Lead developer
- Zhifei Biological
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
The Component DTaP Vaccine is a third-generation acellular pertussis combination vaccine developed by Chongqing Zhifei Biological Products (IPS/Zhifei). It is designed to provide protection against whooping cough (pertussis), diphtheria, and tetanus. Unlike traditional co-purified DTaP vaccines, this formulation utilizes component-purified antigens, including diphtheria toxoid, tetanus toxoid, and specific acellular pertussis antigens. This approach allows for more precise control over the antigen composition, potentially enhancing safety and immunogenicity. The vaccine works by inducing protective antibody-mediated immunity against *Bordetella pertussis*, *Corynebacterium diphtheriae*, and *Clostridium tetani*.
- Other names
- 组份百白破疫苗component-purified DTaP vaccineIPS/Zhifei DTaP vaccinediphtheria toxoid + tetanus toxoid + acellular pertussis vaccine
02
Targets
TT (Tetanus toxoid)
Beyond the preview
Go deeper on Component DTaP Vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Component DTaP Vaccine.